Medpace Sets Q2 2026 Earnings Call for July 22
Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment
Neutral
Importance
7
Price
$461.6
Mkt Cap
$13.183B
52W Low
$294.07
52W High
$628.916
52W Position
57% above low
Off High
27% below high
Rel. Volume
0.6× avg
Market data snapshot near publication time
MEDP sits 57% above its 52-week low of $294.07.
Summary
Medpace Holdings has scheduled its second quarter 2026 financial results release for July 22, 2026. This announcement provides the market with the official date for the upcoming earnings call. Traders will mark this date to prepare for potential market reactions and to assess the company's performance and updated guidance.
At the time of this announcement, MEDP was trading at $461.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $294.07 to $628.92. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.
Price Chart
MEDP - Latest Insights
MEDP
Jul 27, 2026, 4:52 PM EDT
Price at Filing:
$589.37
Real-time Price:
$597.08
Change:
+$7.71 (+1%)
Market Cap:
$16.665B
MEDP
Jul 23, 2026, 4:03 PM EDT
Price at Filing:
$602.02
Real-time Price:
$597.08
Change:
-$4.94 (-0.82%)
Market Cap:
$16.665B
MEDP
Jul 22, 2026, 4:34 PM EDT
Price at Filing:
$605.00
Real-time Price:
$597.08
Change:
-$7.92 (-1%)
Market Cap:
$16.665B
MEDP
Jun 04, 2026, 4:06 PM EDT
Price at Filing:
$458.69
Real-time Price:
$597.08
Change:
+$138.39 (+30%)
Market Cap:
$16.665B
MEDP
May 26, 2026, 6:18 AM EDT
Price at Filing:
$432.80
Real-time Price:
$597.08
Change:
+$164.28 (+38%)
Market Cap:
$16.665B